$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Cynanchum wilfordii Radix attenuates liver fat accumulation and damage by suppressing hepatic cyclooxygenase-2 and mitogen-activated protein kinase in mice fed with a high-fat and high-fructose diet

Nutrition research, v.36 no.9, 2016년, pp.914 - 924  

Jang, S.A. ,  Lee, S. ,  Sohn, E.H. ,  Yang, J. ,  Park, D.W. ,  Jeong, Y.J. ,  Kim, I. ,  Kwon, J.E. ,  Song, H.S. ,  Cho, Y.M. ,  Meng, X. ,  Koo, H.J. ,  Kang, S.C.

Abstract AI-Helper 아이콘AI-Helper

Excessive consumption of fat and fructose augments the pathological progression of nonalcoholic fatty liver disease through hepatic fibrosis, inflammation, and hepatic de novo lipogenesis. We hypothesized that supplementation with Cynanchum wilfordii extract (CWE) decreases fat accumulation in the l...

주제어

참고문헌 (40)

  1. Rev Recent Clin Trials Almeda-Valdes 9 148 2014 10.2174/1574887109666141216103908 Common features of the metabolic syndrome and nonalcoholic fatty liver disease 

  2. Hepatology Browning 40 1387 2004 10.1002/hep.20466 Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity 

  3. Gastroenterol Res Pract Song 2013 2013 10.1155/2013/342648 Time course of the development of nonalcoholic fatty liver disease in the Otsuka Long-Evans Tokushima fatty rat 

  4. J Lipid Res Subramanian 52 1626 2011 10.1194/jlr.M016246 Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice 

  5. Hepatology Yu 43 826 2006 10.1002/hep.21108 COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator 

  6. Gastroenterology Day 114 842 1998 10.1016/S0016-5085(98)70599-2 Steatohepatitis: a tale of two “hits”? 

  7. Cochrane Database Syst Rev Eslami 12 CD008623 2013 Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis 

  8. Metabolism Aguilar-Olivos 2015 The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome 

  9. J Ethnopharmacol Shan 107 389 2006 10.1016/j.jep.2006.03.022 Gastroprotective effect of a traditional Chinese herbal drug “Baishouwu” on experimental gastric lesions in rats 

  10. Arch Pharm Res Jiang 34 2021 2011 10.1007/s12272-011-1203-z Chemical constituents of Cynanchum wilfordii and the chemotaxonomy of two species of the family Asclepiadacease, C. wilfordii and C. auriculatum 

  11. Prev Nutr Food Sci Lee 18 157 2013 10.3746/pnf.2013.18.3.157 Effects of the Cynanchum wilfordii ethanol extract on the serum lipid profile in hypercholesterolemic rats 

  12. J Med Food Choi 15 169 2012 10.1089/jmf.2010.1222 Improved endothelial dysfunction by Cynanchum wilfordii in apolipoprotein E−/− mice fed a high fat/cholesterol diet 

  13. Biol Pharm Bull Yang 37 1390 2014 10.1248/bpb.b13-00939 Cynandione A from Cynanchum wilfordii attenuates the production of inflammatory mediators in LPS-induced BV-2 microglial cells via NF-κB inactivation 

  14. Hypertension Ackerman 45 1012 2005 10.1161/01.HYP.0000164570.20420.67 Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction 

  15. J Hepatol Ouyang 48 993 2008 10.1016/j.jhep.2008.02.011 Fructose consumption as a risk factor for non-alcoholic fatty liver disease 

  16. Hepatology Farrell 43 S99 2006 10.1002/hep.20973 Nonalcoholic fatty liver disease: from steatosis to cirrhosis 

  17. Mol Med Rep Chen 4 811 2011 Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats 

  18. Hepatol Res Cheng 23 185 2002 10.1016/S1386-6346(01)00177-2 Expression of cyclooxygenase 2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis 

  19. Clin Cancer Res Kondo 5 4005 1999 Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma 

  20. Prostaglandins Leukot Essent Fatty Acids Hu 69 329 2003 10.1016/j.plefa.2003.07.001 Cyclooxygenase 2 (COX2)-prostanoid pathway and liver diseases 

  21. J Clin Exp Hepatol Sharma 5 147 2015 10.1016/j.jceh.2015.02.002 The riddle of nonalcoholic fatty liver disease: progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis 

  22. Int J Clin Exp Med Zeng 7 1624 2014 Signal transductions and nonalcoholic fatty liver: a mini-review 

  23. World J Gastroenterol Basaranoglu 19 1166 2013 10.3748/wjg.v19.i8.1166 Fructose as a key player in the development of fatty liver disease 

  24. Int J Mol Med Koo 35 915 2015 10.3892/ijmm.2015.2112 An ethanol root extract of Cynanchum wilfordii containing acetophenones suppresses the expression of VCAM-1 and ICAM-1 in TNF-α-stimulated human aortic smooth muscle cells through the NF-κB pathway 

  25. Exp Biol Med (Maywood) Meng 241 396 2016 10.1177/1535370215614657 Anti-inflammatory effects of Saururus chinensis aerial parts in murine macrophages via induction of heme oxygenase-1 

  26. Behav Res Methods Faul 39 175 2007 10.3758/BF03193146 G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences 

  27. Hepatol Int de Moraes 5 965 2011 10.1007/s12072-011-9275-x Protective effects of green tea against hepatic injury induced by high-cholesterol diet in rats: histopathological analysis, oxidative DNA damage and COX-2 expression 

  28. Am J Physiol Lung Cell Mol Physiol Singer 285 L1087 2003 10.1152/ajplung.00409.2002 p38 MAPK and NF-kappaB mediate COX-2 expression in human airway myocytes 

  29. Prostaglandins Other Lipid Mediat Tanabe 68-69 95 2002 10.1016/S0090-6980(02)00024-2 Cyclooxygenase isozymes and their gene structures and expression 

  30. ISRN Endocrinol Matsuda 2013 472432 2013 10.1155/2013/472432 Roles for PI3K/AKT/PTEN pathway in cell signaling of nonalcoholic fatty liver disease 

  31. J Dig Dis Demir 16 10 541 2015 10.1111/1751-2980.12291 Nonalcoholic fatty liver disease: current status and future directions 

  32. Environ Health Prev Med Kitamori 17 173 2012 10.1007/s12199-011-0235-9 Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr 

  33. World J Gastroenterol Milic 20 9330 2014 Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations 

  34. World J Hepatol Zambo 5 550 2013 10.4254/wjh.v5.i10.550 Lipotoxicity in the liver 

  35. Exp Gerontol Wang 48 705 2013 10.1016/j.exger.2013.05.059 Prevalence and associated metabolic factors of fatty liver disease in the elderly 

  36. Ann N Y Acad Sci Giannitrapani 1155 293 2009 10.1111/j.1749-6632.2009.03698.x Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study 

  37. Obesity (Silver Spring) Hsieh 17 1150 2009 10.1038/oby.2008.674 COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver 

  38. Science Cannon 336 1386 2012 10.1126/science.1224398 Physiology. COX-2 inhibitors and cardiovascular risk 

  39. J Hepatol Leclercq 41 926 2004 10.1016/j.jhep.2004.08.010 . Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice 

  40. Hepatology Matsuzawa 46 1392 2007 10.1002/hep.21874 Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로